MedTrace Logo

Neuroinflammatory Response in Patients With ICH and IVH Treated With rtPA

NCT03452722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2019-03-26

No results posted yet for this study

Summary

This study compares the neuroinflammatory response in patients with hypertensive ICH associated with IVH treated with intraventriculary applied rtPA, and the control group. The inflammatory mediator concentration is analyzed in local cerebrospinal liquor.

Conditions

  • Hypertensive Intracerebral Hemorrhage
  • Intraventricular Hemorrhage
  • Brain Injuries

Interventions

DRUG

intraventricual recombinant tissue plasminogen activator application

Sponsors & Collaborators

  • University of Rijeka

    lead OTHER

Principal Investigators

  • Vlatka Sotosek Tokmadzic, PhD · University of Rijeka

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-01
Primary Completion
2017-08-01
Completion
2018-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03452722 on ClinicalTrials.gov